172 / 220
[23]
Paleri V, Roe JW, Strojan P, et al. Strategies to reduce long-term postchemoradiation dysphagia in patients with head and neck cancer: an evidence-based review. Head Neck 2014;36:431–43 .[24]
Frowen JJ, Perry AR. Swallowing outcomes after radiotherapy for head and neck cancer: a systematic review. Head Neck 2006;28:932–44 .[25]
Chen AY, Frankowski R, Bishop-Leone J, et al. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M.D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg 2001;127:870–6 .[26]
Prestwich RJ, Oksuz DC, Dyker K, Coyle C, Sen M. Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic stage IV head- and-neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 2011;81: e237–43 .[27]
Prestwich RJ, Kancherla K, Oksuz DC, et al. A single centre experience with sequential and concomitant chemoradiotherapy in locally advanced stage IV tonsillar cancer. Radiat Oncol 2010;5:121 .[28]
Bayman E, Prestwich RJ, Speight R, et al. Patterns of failure after intensity- modulated radiotherapy in head and neck squamous cell carcinoma using compartmental clinical target volume delineation. Clin Oncol (R Coll Radiol) 2014;26:636–42 .[29]
Gregoire V, Levendag P, Ang KK, et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 2003;69:227–36.
[30]
Mekhail TM, Adelstein DJ, Rybicki LA, Larto MA, Saxton JP, Lavertu P. Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube? Cancer 2001;91:1785–90 .[31]
Corry J. Feeding tubes and dysphagia: cause or effect in head and neck cancer patients. J Med Imaging Radiat Oncol 2009;53:431–2.
[32]
Oozeer NB, Corsar K, Glore RJ, Penney S, Patterson J, Paleri V. The impact of enteral feeding route on patient-reported long term swallowing outcome after chemoradiation for head and neck cancer. Oral Oncol 2011;47:980–3 .[33]
Shaw SM, Flowers H, O’Sullivan B, Hope A, Liu LW, Martino R. The effect of prophylactic percutaneous endoscopic gastrostomy (PEG) tube placement on swallowing and swallow-related outcomes in patients undergoing radiotherapy for head and neck cancer: a systematic review. Dysphagia 2015;30:152–75 .[34]
Paleri V, Patterson J. Use of gastrostomy in head and neck cancer: a systematic review to identify areas for future research. Clin Otolaryngol 2010;35:177–89 .[35] A feasibility randomised controlled trial of pre-treatment gastrostomy tube
versus oral feeding plus as-needed nasogastric tube feeding in patients
undergoing chemoradiation for head and neck cancer (TUBE trial).
< http:// wwwnetsnihracuk/projects/hta/123532> [accessed 06/06/2016].
[36]
Corry J, Poon W, McPhee N, et al. Randomized study of percutaneous endoscopic gastrostomy versus nasogastric tubes for enteral feeding in head and neck cancer patients treated with (chemo)radiation. J Med Imaging Radiat Oncol 2008;52:503–10 .[37]
Nutting CM, Morden JP, Harrington KJ, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011;12:127–36.
[38]
Gluck I, Feng FY, Lyden T, et al. Evaluating and reporting dysphagia in trials of chemoirradiation for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2010;77:727–33 .B. Sethugavalar et al. / Oral Oncology 59 (2016) 80–85
152